Thrivent Financial for Lutherans’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Hold |
17,526
| – | – | ﹤0.01% | 2069 |
|
|
2025
Q1 | $514K | Hold |
17,526
| – | – | ﹤0.01% | 2059 |
|
|
2024
Q4 | $576K | Sell |
17,526
-7,077
| -29% | -$233K | ﹤0.01% | 2192 |
|
|
2024
Q3 | $1.09M | Hold |
24,603
| – | – | ﹤0.01% | 1859 |
|
|
2024
Q2 | $1.06M | Sell |
24,603
-1,051
| -4% | -$45.3K | ﹤0.01% | 1833 |
|
|
2024
Q1 | $750K | Hold |
25,654
| – | – | ﹤0.01% | 2052 |
|
|
2023
Q4 | $572K | Sell |
25,654
-19,151
| -43% | -$427K | ﹤0.01% | 2154 |
|
|
2023
Q3 | $1.11M | Buy |
44,805
+22
| +0% | +$545 | ﹤0.01% | 1672 |
|
|
2023
Q2 | $1.27M | Sell |
44,783
-2,196
| -5% | -$62.2K | ﹤0.01% | 1646 |
|
|
2023
Q1 | $1.08M | Hold |
46,979
| – | – | ﹤0.01% | 1744 |
|
|
2022
Q4 | $1.32M | Sell |
46,979
-564
| -1% | -$15.8K | ﹤0.01% | 1551 |
|
|
2022
Q3 | $1.34M | Sell |
47,543
-55,776
| -54% | -$1.58M | ﹤0.01% | 1483 |
|
|
2022
Q2 | $2.29M | Buy |
+103,319
| New | +$2.29M | 0.01% | 1152 |
|
|
2021
Q1 | – | Sell |
-350,768
| Closed | -$15.2M | – | 2521 |
|
|
2020
Q4 | $15.2M | Buy |
350,768
+86,829
| +33% | +$3.76M | 0.04% | 521 |
|
|
2020
Q3 | $9.24M | Sell |
263,939
-7,119
| -3% | -$249K | 0.02% | 623 |
|
|
2020
Q2 | $14.5M | Buy |
271,058
+1,387
| +0.5% | +$74.2K | 0.04% | 451 |
|
|
2020
Q1 | $9.57M | Buy |
269,671
+938
| +0.3% | +$33.3K | 0.03% | 508 |
|
|
2019
Q4 | $12.8M | Buy |
268,733
+28,944
| +12% | +$1.38M | 0.04% | 507 |
|
|
2019
Q3 | $7.77M | Buy |
+239,789
| New | +$7.77M | 0.02% | 568 |
|